+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
14-Alpha Demethylase Inhibitor Market - Global Forecast 2026-2032- Product Image
14-Alpha Demethylase Inhibitor Market - Global Forecast 2026-2032- Product Image
Sale

14-Alpha Demethylase Inhibitor Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6153840
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The 14-Alpha Demethylase Inhibitor Market is projected to reach USD 1.43 Billion in 2026. It is expected to continue growing at a CAGR of 4.84%, reaching USD 1.89 Billion by 2032.

14-Alpha Demethylase Inhibitors: Executive Overview

14-alpha demethylase inhibitors are antifungal agents that disrupt ergosterol biosynthesis, weakening fungal cell membranes. Their relevance spans human medicine, veterinary applications, and crop protection, although regulatory status, approved uses, and evidence standards differ substantially across these settings. The market is shaped by infection burden, resistance management, product safety, formulation performance, and stewardship requirements.

Shifts Reshaping Antifungal Development and Use

The landscape is moving from reliance on established azole chemistry toward more targeted, evidence-led treatment strategies. Important shifts include greater attention to azole-resistant organisms, combination or sequential therapy, improved delivery systems, environmental persistence, and tighter evaluation of cross-resistance. In agriculture, integrated pest-management programs are increasing the emphasis on rotation, label compliance, and nonchemical controls rather than repeated use of a single mode of action.

Artificial Intelligence Strengthens Discovery, Surveillance, and Stewardship

Artificial intelligence can support this field by prioritizing molecular candidates, predicting binding and toxicity signals, analyzing susceptibility data, and identifying patterns associated with treatment failure. It can also improve image-based diagnosis, resistance surveillance, formulation optimization, and agricultural disease monitoring. Effective deployment still requires validated datasets, transparent model evaluation, laboratory confirmation, privacy safeguards, and human oversight because biological variability and incomplete surveillance can produce misleading outputs.

Regional Insights Across Six Major Geographies

North America emphasizes clinical stewardship, resistance monitoring, and regulatory evidence, while Latin America combines substantial agricultural demand with varied healthcare access and regulatory capacity. Europe places strong weight on antimicrobial stewardship, environmental assessment, and coordinated regulation. The Middle East faces uneven access, climate-linked agricultural pressures, and the need for resilient distribution systems. Africa’s priorities include diagnostic capacity, affordability, supply continuity, and crop-protection access. Asia-Pacific presents diverse requirements spanning advanced research systems, large agricultural sectors, infectious-disease management, and differing national standards.

Group-Level Priorities Across Global Blocs

ASEAN markets require adaptable registration, distribution, and stewardship approaches that reflect varied health systems and agricultural practices. BRICS members combine major research, production, and farming capabilities with significant regulatory diversity, making interoperability and evidence exchange important. The European Union centers on harmonized assessment, environmental safeguards, and resistance containment. G7 economies generally prioritize advanced diagnostics, product quality, and post-market surveillance. GCC countries emphasize import resilience, clinical access, and food-security applications, while NATO members benefit from coordinated preparedness and supply-chain planning for health-security risks.

Country-Level Signals for Strategic Planning

Australia emphasizes biosecurity, resistance management, and agricultural stewardship. Brazil combines major crop-protection needs with a large healthcare system and rigorous attention to registration and responsible use. Canada prioritizes antimicrobial stewardship, environmental review, and access across dispersed populations. China and India are important for manufacturing, agricultural applications, domestic research, and evolving regulatory oversight. Japan and South Korea focus on high-quality clinical evidence, advanced formulation, and technology-enabled monitoring. France, Germany, Italy, and Spain operate within European regulatory and stewardship frameworks, with strong attention to healthcare quality and sustainable agriculture. The United Kingdom emphasizes independent regulatory review, resistance surveillance, and health-system stewardship. Mexico faces the need to balance agricultural productivity, healthcare access, and regulatory consistency. Russia’s environment is shaped by domestic production objectives, agricultural requirements, and evolving access conditions. The United States places particular weight on clinical evidence, resistance surveillance, product safety, and integrated pest management.

Actions for Industry Leaders in Antifungal Innovation

Leaders should build portfolios around differentiated mechanisms, improved tolerability, practical formulations, and resistance-management value rather than novelty alone. They should establish country-specific regulatory plans, invest in validated susceptibility and diagnostic capabilities, and generate evidence across clinical, veterinary, agricultural, and environmental settings where relevant. Partnerships with laboratories, healthcare systems, growers, and public agencies can strengthen surveillance and stewardship. Digital and AI tools should be introduced through controlled pilots with clear performance thresholds, while supply-chain redundancy, quality systems, and transparent environmental assessments should remain core operating priorities.

Research Methodology for the Executive Summary

This summary uses the supplied market scope-14-alpha demethylase inhibitors-and organizes analysis across applications, technology, regulation, geography, and stakeholder groups. Insights are framed qualitatively from established characteristics of ergosterol-biosynthesis inhibition, antifungal resistance, stewardship, diagnostics, formulation development, and regional policy environments. No market estimates, forecasts, market shares, or company-level claims are included. Country and group observations are presented as strategic context and should be validated against current regulatory decisions, clinical guidance, surveillance records, and local agricultural rules before operational use.

Conclusion: Compete Through Evidence, Stewardship, and Resilience

The 14-alpha demethylase inhibitor landscape is defined by the tension between continuing need for effective fungal control and rising demands for safety, resistance containment, environmental responsibility, and reliable access. Durable progress will depend on differentiated science, stronger diagnostics, coordinated surveillance, and disciplined use across human health and agriculture. Organizations that connect innovation with regional regulatory insight, responsible stewardship, and resilient supply planning will be better positioned to address changing biological and policy conditions.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. 14-Alpha Demethylase Inhibitor Market, by Drug Type
7.1. Introduction
7.2. Imidazoles
7.2.1. Clotrimazole
7.2.2. Ketoconazole
7.2.3. Miconazole
7.3. Triazoles
7.3.1. Fluconazole
7.3.2. Itraconazole
7.3.3. Voriconazole
8. 14-Alpha Demethylase Inhibitor Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
8.3.1. Capsule
8.3.2. Suspension
8.3.3. Tablet
8.4. Topical
8.4.1. Cream
8.4.2. Gel
8.4.3. Ointment
9. 14-Alpha Demethylase Inhibitor Market, by Application
9.1. Introduction
9.2. Dermatological Infections
9.2.1. Candidiasis
9.2.2. Onychomycosis
9.2.3. Tinea Pedis
9.3. Prophylaxis
9.3.1. Immunocompromised Patients
9.3.2. Surgical Prophylaxis
9.4. Systemic Infections
9.4.1. Aspergillosis
9.4.2. Candidemia
9.4.3. Cryptococcosis
10. 14-Alpha Demethylase Inhibitor Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. 14-Alpha Demethylase Inhibitor Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. 14-Alpha Demethylase Inhibitor Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. 14-Alpha Demethylase Inhibitor Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AbbVie Inc.
15.2. AstraZeneca plc
15.3. Bayer AG
15.4. Bristol-Myers Squibb Company
15.5. Eli Lilly and Company
15.6. GlaxoSmithKline plc
15.7. Johnson & Johnson Services, Inc.
15.8. Merck & Co., Inc.
15.9. Mycovia Pharmaceuticals, Inc.
15.10. Novartis AG
15.11. Pfizer Inc.
15.12. Sanofi S.A.
15.13. Sun Pharmaceutical Industries Ltd.
15.14. Teva Pharmaceutical Industries Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global 14-Alpha Demethylase Inhibitor Market, Years Considered for the Study
FIGURE 2. Global 14-Alpha Demethylase Inhibitor Market, Research Design
FIGURE 3. Global 14-Alpha Demethylase Inhibitor Market, Research Framework
FIGURE 4. Global 14-Alpha Demethylase Inhibitor Market, Data Triangulation
FIGURE 5. Global 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
FIGURE 6. Global 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 7. Global 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global 14-Alpha Demethylase Inhibitor Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global 14-Alpha Demethylase Inhibitor Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global 14-Alpha Demethylase Inhibitor Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global 14-Alpha Demethylase Inhibitor Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global 14-Alpha Demethylase Inhibitor Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global 14-Alpha Demethylase Inhibitor Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global 14-Alpha Demethylase Inhibitor Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global 14-Alpha Demethylase Inhibitor Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global 14-Alpha Demethylase Inhibitor Market Segmentation & Coverage
TABLE 2. Global 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 3. Global 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 4. Global Imidazoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Imidazoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Imidazoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Clotrimazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Clotrimazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Clotrimazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Ketoconazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Ketoconazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Ketoconazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Miconazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Miconazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Miconazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Triazoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Triazoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Triazoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Fluconazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Fluconazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Fluconazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Itraconazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Itraconazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Itraconazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Voriconazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Voriconazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Voriconazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 29. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Cream Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cream Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cream Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Gel Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Gel Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Gel Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Ointment Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Ointment Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Ointment Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Global Dermatological Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Dermatological Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Dermatological Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Candidiasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Candidiasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Candidiasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Onychomycosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Onychomycosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Onychomycosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Tinea Pedis Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Tinea Pedis Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Tinea Pedis Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Immunocompromised Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Immunocompromised Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Immunocompromised Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Surgical Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Surgical Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Surgical Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Systemic Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Systemic Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Systemic Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Aspergillosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Aspergillosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Aspergillosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Candidemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Candidemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Candidemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Cryptococcosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Cryptococcosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Cryptococcosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global 14-Alpha Demethylase Inhibitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. North America 14-Alpha Demethylase Inhibitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. North America 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 115. North America 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 116. North America 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 117. North America 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 118. North America 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 119. North America 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 120. North America 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. North America 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 122. North America 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 123. North America 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 124. North America 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 127. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 128. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 129. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 130. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 131. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 132. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 134. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 135. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 136. Latin America 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. Europe 14-Alpha Demethylase Inhibitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Europe 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 139. Europe 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 140. Europe 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 141. Europe 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 142. Europe 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 143. Europe 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 144. Europe 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. Europe 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 146. Europe 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 147. Europe 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 148. Europe 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 151. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 152. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 153. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 154. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 155. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 156. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 158. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 159. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 160. Middle East 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Africa 14-Alpha Demethylase Inhibitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Africa 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 163. Africa 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 164. Africa 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 165. Africa 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 166. Africa 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 167. Africa 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 168. Africa 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Africa 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 170. Africa 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 171. Africa 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 172. Africa 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. Global 14-Alpha Demethylase Inhibitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 176. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 177. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 178. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 179. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 180. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 181. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 183. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 184. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 185. ASEAN 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. GCC 14-Alpha Demethylase Inhibitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. GCC 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 188. GCC 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 189. GCC 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 190. GCC 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 191. GCC 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 192. GCC 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 193. GCC 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. GCC 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 195. GCC 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 196. GCC 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 197. GCC 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. European Union 14-Alpha Demethylase Inhibitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. European Union 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 200. European Union 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 201. European Union 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 202. European Union 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 203. European Union 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 204. European Union 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 205. European Union 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. European Union 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 207. European Union 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 208. European Union 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 209. European Union 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 212. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 213. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 214. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 215. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 216. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 217. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 219. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 220. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 221. BRICS 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. G7 14-Alpha Demethylase Inhibitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. G7 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 224. G7 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 225. G7 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 226. G7 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 227. G7 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 228. G7 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 229. G7 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. G7 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 231. G7 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 232. G7 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 233. G7 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. NATO 14-Alpha Demethylase Inhibitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. NATO 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 236. NATO 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 237. NATO 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 238. NATO 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 239. NATO 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 240. NATO 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 241. NATO 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. NATO 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 243. NATO 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 244. NATO 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 245. NATO 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. Global 14-Alpha Demethylase Inhibitor Market Size, by Country, 2017-2032 (USD Million)
TABLE 247. United States 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 248. United States 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 249. United States 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 250. United States 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 251. United States 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 252. United States 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 253. United States 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 254. United States 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. United States 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 256. United States 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 257. United States 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 258. United States 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. Canada 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 260. Canada 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 261. Canada 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 262. Canada 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 263. Canada 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 264. Canada 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 265. Canada 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 266. Canada 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Canada 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 268. Canada 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 269. Canada 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 270. Canada 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. Mexico 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 272. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 273. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 274. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 275. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 276. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 277. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 278. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 280. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 281. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 282. Mexico 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 283. Brazil 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 284. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 285. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 286. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 287. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 288. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 289. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 290. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 292. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 293. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 294. Brazil 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 296. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 297. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 298. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 299. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 300. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 301. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 302. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 304. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 305. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 306. United Kingdom 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Germany 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 308. Germany 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 309. Germany 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 310. Germany 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 311. Germany 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 312. Germany 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 313. Germany 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 314. Germany 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 315. Germany 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 316. Germany 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 317. Germany 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 318. Germany 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 319. France 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 320. France 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 321. France 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 322. France 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 323. France 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 324. France 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD Million)
TABLE 325. France 14-Alpha Demethylase Inhibitor Market Size, by Topical, 2017-2032 (USD Million)
TABLE 326. France 14-Alpha Demethylase Inhibitor Market Size, by Application, 2017-2032 (USD Million)
TABLE 327. France 14-Alpha Demethylase Inhibitor Market Size, by Dermatological Infections, 2017-2032 (USD Million)
TABLE 328. France 14-Alpha Demethylase Inhibitor Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 329. France 14-Alpha Demethylase Inhibitor Market Size, by Systemic Infections, 2017-2032 (USD Million)
TABLE 330. France 14-Alpha Demethylase Inhibitor Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 331. Russia 14-Alpha Demethylase Inhibitor Market Size, 2017-2032 (USD Million)
TABLE 332. Russia 14-Alpha Demethylase Inhibitor Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 333. Russia 14-Alpha Demethylase Inhibitor Market Size, by Imidazoles, 2017-2032 (USD Million)
TABLE 334. Russia 14-Alpha Demethylase Inhibitor Market Size, by Triazoles, 2017-2032 (USD Million)
TABLE 335. Russia 14-Alpha Demethylase Inhibitor Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 336. Russia 14-Alpha Demethylase Inhibitor Market Size, by Oral, 2017-2032 (USD

Companies Mentioned

  • AbbVie Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bristol‑Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mycovia Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Marine enzymes and specialized metabolism - Part B. Methods in Enzymology Volume 605 - Product Image

Marine enzymes and specialized metabolism - Part B. Methods in Enzymology Volume 605

  • Book
Non-heme Iron Enzymes: Structures and Mechanisms. Advances in Protein Chemistry and Structural Biology Volume 117 - Product Image

Non-heme Iron Enzymes: Structures and Mechanisms. Advances in Protein Chemistry and Structural Biology Volume 117

  • Book
Alpha Glucosidase Inhibitors Market Report 2026 - Product Image

Alpha Glucosidase Inhibitors Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Alpha Glucosidase Inhibitors Market - Global Forecast 2026-2032 - Product Image

Alpha Glucosidase Inhibitors Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Alpha Glucosidase Inhibitors - Global Strategic Business Report - Product Image

Alpha Glucosidase Inhibitors - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.